CORT has opened the NCCTG N063D (BIG 2-06) study for adjuvant therapy of her-2 positive breast cancer. This study is a worldwide study funded by the National Cancer Institute Cooperative Group (NCCTG). It is known as the ALLTO study. …
Original post:
ALLTO Study Evaluates the Role of Lapatinib (Tykerb) in Adjuvant …
0 responses so far ↓
There are no comments yet...Kick things off by filling out the form below.
You must log in to post a comment.